Nuwellis (NUWE) Receivables (2013 - 2026)
Nuwellis' (NUWE) quarterly Receivables came in at $1.5 million in Q2 2026, up 29.51% on a YoY basis from $1.2 million in Q2 2025, and down 0.9% quarter-over-quarter from $1.6 million in Q1 2026.
Analysis
Nuwellis (NUWE) Receivables (2013 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Receivables for 14 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables rose 29.51% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2026 stood at $1.5 million (up 29.51% YoY), and the FY2025 full-year result was $1.5 million, down 13.55% from the prior year.
- Receivables slipped to $1.5 million in Q2 2026 per NUWE's latest filing, from $1.6 million in the prior quarter.
- Across five years, Receivables topped out at $2.0 million in Q4 2023 and bottomed at $951000.0 in Q1 2022.
- Historically, Receivables has averaged $1.4 million across 5 years, with a median of $1.3 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Receivables jumped 87.47% in 2022, then declined 13.55% in 2025.
- Over 5 years, Receivables stood at $1.4 million in 2022, then surged by 38.76% to $2.0 million in 2023, then retreated by 11.48% to $1.7 million in 2024, then declined by 13.55% to $1.5 million in 2025, then advanced by 3.48% to $1.5 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $1.5 million, $1.6 million, and $1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.67 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 6.36 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.74 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 3.18 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 955.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 2.08 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 1.28 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | 1.49 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 951,000.00 |
| Dec 31, 2021 | 750,000.00 |
| Sep 30, 2021 | 1.07 Mn |